Seebri Neohaler Interactions
There are 202 drugs known to interact with Seebri Neohaler (glycopyrrolate), along with 15 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 4 are major, 181 are moderate, and 17 are minor.
- View all 202 medications that may interact with Seebri Neohaler
- View Seebri Neohaler alcohol/food interactions (2)
- View Seebri Neohaler disease interactions (15)
Most frequently checked interactions
View interaction reports for Seebri Neohaler (glycopyrrolate) and the medicines listed below.
- acrivastine
- Advair Diskus (fluticasone / salmeterol)
- Advair HFA (fluticasone / salmeterol)
- albuterol
- allopurinol
- amlodipine
- Anoro Ellipta (umeclidinium / vilanterol)
- Arcapta (indacaterol)
- aspirin
- atorvastatin
- Atrovent (ipratropium)
- Atrovent HFA (ipratropium)
- Breo Ellipta (fluticasone / vilanterol)
- candesartan
- carbocysteine
- cetirizine
- clarithromycin
- colchicine
- Combivent (albuterol / ipratropium)
- Incruse Ellipta (umeclidinium)
- montelukast
- Plavix (clopidogrel)
- pregabalin
- ramipril
- Spiriva (tiotropium)
- Spiriva Respimat (tiotropium)
- Symbicort (budesonide / formoterol)
- Ventolin (albuterol)
- Ventolin HFA (albuterol)
- Vitamin D3 (cholecalciferol)
Seebri Neohaler alcohol/food interactions
There are 2 alcohol/food interactions with Seebri Neohaler (glycopyrrolate).
Seebri Neohaler disease interactions
There are 15 disease interactions with Seebri Neohaler (glycopyrrolate) which include:
- arrhythmias
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- tardive dyskinesia
- infectious diarrhea
- myasthenia gravis
- ulcerative colitis
- psychoses
- Down's syndrome
- liver impairment
- renal impairment
- hypertension
- fever
More about Seebri Neohaler (glycopyrrolate)
- Seebri Neohaler consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anticholinergic bronchodilators
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.